About Allaria
Overview
Allaria is a financial services provider registered in Spain and operating from an address in Buenos Aires, Argentina. According to public records, the company was founded on August 5, 2019, though it claims a founding year of 1995. The firm offers a range of traditional investment products including stocks, bonds, derivatives, and mutual funds.
Allaria maintains a social media presence across Facebook, Instagram, LinkedIn, and Twitter/X, suggesting an active effort to engage with clients. However, the broker does not hold any regulatory license from a recognized financial authority, which significantly limits its oversight and client protection mechanisms.
Company Background
Allaria states it was founded in Spain in 1995, but official registration records show a founding date of August 5, 2019. This discrepancy raises questions about the broker's operational history. The registered address is at 25 de Mayo 359 piso 12°, CABA, Argentina, indicating a strong local presence in the Argentine market.
Despite its Spanish registration, all available evidence points to Allaria primarily serving clients in Argentina and possibly other Latin American markets. The lack of regulatory oversight from bodies such as the CNMV (Spain) or CNV (Argentina) means there is no independent verification of the firm's financial health or operational standards.
Products and Services
Allaria offers a variety of financial instruments including stocks, bonds, derivatives, and mutual funds. This places it as a traditional stockbroker rather than a forex or CFD broker. The firm emphasizes its comprehensive market analysis and research resources as tools to help clients make informed investment decisions.
However, the broker acknowledges high commission fees and limited access to international markets as drawbacks. This suggests that Allaria may be more suitable for local Argentine investors seeking domestic market exposure rather than those requiring global trading capabilities.
Client Support and Resources
Allaria promotes accessible customer support and robust research resources. The company's social media channels are likely used to distribute market insights and engage with clients. The firm's website (allaria.com.ar) appears to be the primary platform for account management and trading.
Given the unregulated status, the quality and reliability of client support cannot be independently verified. Traders should exercise caution when relying on research provided by an unlicensed entity.
Account Types and Trading Platforms
No specific account types or trading platforms are detailed in the available information. As a traditional stockbroker, Allaria likely offers standard brokerage accounts for trading local securities. The absence of information on platforms like MetaTrader or web-based trading systems suggests a more conventional approach to order execution.
Without clear details on fees, minimum deposits, or platform features, potential clients should seek further clarification directly from the broker before committing funds.
Regulatory and Safety Considerations
Allaria does not hold any regulatory license from a recognized financial authority. This is a significant red flag for investors, as unregulated brokers offer no recourse through ombudsman services or compensation schemes. The FXCanary Scam Risk Score of 43/100 (Guarded) reflects this lack of oversight.
In FXCanary's assessment, the absence of regulation combined with the discrepancy in founding dates reduces confidence in the broker's transparency. Traders should consider this a high-risk environment and only invest funds they can afford to lose.
Suitability
Allaria may be suitable for Argentine investors comfortable with a local, unregulated broker and primarily interested in domestic stocks, bonds, and mutual funds. The firm's research resources and support could benefit those who value localized service.
However, it is not suitable for traders seeking regulated environments, international market access, low fees, or leverage products like forex and CFDs. The lack of regulatory safeguards makes it a particularly poor choice for risk-averse investors.
Overview compiled by FXCanary from regulatory records and public data. full Allaria review